Avelios Medical closes funding round to digitize German hospitals
November 2, 2021
- The 2 million Euro financing round is led by Revent, further investors are High-Tech Gründerfonds and renowned business angels
- The Munich-based startup digitizes workflows in hospitals with innovative software and enables data-driven patient care
Munich, November 2, 2021 – Avelios Medical, a modular software platform for the digitization of workflows in hospitals and data-driven patient care, has closed a seed funding round of 2 million Euro from Revent, High-Tech Gründerfonds and the founders of Amboss and Oviva.
To address the lack of digitization in healthcare, Avelios has developed a modular software platform that digitizes and optimizes processes in hospitals with state-of-the-art software in a user-friendly way. For example, Avelios’ outpatient and ward module digitize all workflows and enable a fully digital documentation of patient care with innovative features such as an automatically generated doctor’s letter or intelligent input fields.
The company will use the fresh capital to further accelerate the ongoing rollout of the Avelios software in various hospitals as well as the development of additional software modules.
Avelios Medical was founded in 2020 by Nicolas Jakob, Dr. Sebastian Krammer and Christian Albrecht with the vision of becoming the leading software platform for the data-driven digitization of patient care.
AI can fundamentally improve healthcare, but only based on structured data that currently does not exist. Avelios is deliberately digitizing patient care in a way that precisely this missing structured data can be automatically generated and its full potential realized.
Nicolas Jakob, Co-Founder Avelios Medical
Digitizing healthcare to improve patient care is more necessary than ever, and hospitals often lag particularly far behind when it comes to digital workflows and the use of modern software. This leads to extremely inefficient processes, disconnected legacy systems, and a complete lack of useful digital data.
The frustration with incredible inefficiencies and inadequate software solutions that I’ve experienced as a physician myself is the biggest motivation to continually develop software that solves this big problem.
Dr. Sebastian Krammer, Co-Founder Avelios Medical
In addition to the fundamental digitization of workflows, the innovative Avelios software automatically generates fully structured treatment data. This enables data-driven research, business intelligence and billing, as well as the direct integration of AI algorithms to exploit enormous, previously untapped potential. In addition, the modular platform approach enables flexible interfaces to existing legacy systems as well as the integration of modern software solutions and devices.
It’s unbelievable that something as important and big as healthcare has such dramatic deficits in digitization. Our mission is to become the digital backbone of hospitals and enable data-driven healthcare.
Christian Albrecht, Co-Founder Avelios Medical
Added value for hospitals
The Avelios software offers several concrete benefits for hospitals. Digitized workflows and a fast, complete documentation significantly increase process efficiency and employee and patient satisfaction. A low implementation effort, complete modularity and interoperability, and continuous updates are further very attractive for IT departments in hospitals. The software is already successfully in use in the outpatient clinic and laboratory at the LMU Klinikum in Munich, and Avelios is currently rolling out its solution in other hospitals and departments.
We see enormous potential in Avelios to fundamentally improve the quality of treatment in hospitals. The unique modular software platform enables hospitals to build a modern and scalable IT infrastructure without implementation effort.
Henrik Große Hokamp, Partner Revent
In many hospitals processes are still pen- and paper based. We believe that the digital revolution in hospitals will accelerate and that the strong Avelios team has what it takes to become a major player in this field.
Daniela Bach, Senior Investment Manager at High-Tech Gründerfonds
About Avelios Medical
Avelios Medical offers a modular software platform for the digitization of workflows in hospitals and data-driven patient care. The state-of-the-art software digitizes and optimizes all workflows in hospitals in a user-friendly manner, offering numerous innovative functions such as an automatically generated doctor’s letter or intelligent input fields for the documentation of patient treatment. In addition, the software automatically generates fully structured data, enabling the direct use of data-driven use cases and AI algorithms. The company is based in Munich and was founded in 2020 by Nicolas Jakob, Dr. Sebastian Krammer and Christian Albrecht.
Media contact
Avelios Medical GmbH
Christian Albrecht
info@avelios.com
www.avelios.com
About Revent
Founded in 2020, the Berlin-based VC fund invests across Europe in startups with a clear purpose, using technology to drive systemic change in the areas of climate, health and economic empowerment. The Revent team believes that tomorrow’s best companies will emerge where today’s greatest environmental and societal challenges lie.
www.revent.vc
About High-Tech Gründerfonds
High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven start-ups. With around EUR 900 million in total investment volume across three funds and an international network of partners, HTGF has already helped forge more than 650 start-ups since 2005. Driven by their expertise, entrepreneurial spirit and passion, its team of experienced investment managers and startup experts help guide the development of young companies. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial technology, life sciences, chemistry and related business areas. To date, external investors have injected more than EUR 3.5 billion into the HTGF portfolio via more than 1,800 follow-on financing rounds. HTGF has also successfully sold interests in more than 140 companies.
Investors in this public-private partnership include the Federal Ministry For Economic Affairs and Energy, KfW Capital, and Fraunhofer-Gesellschaft e.V., as well as the companies ALTANA, BASF, BAYER, B.Braun, Boehringer Ingelheim, Robert Bosch, BÜFA, CEWE, Deutsche Bank, Deutsche Post DHL, Dräger, 1+1 AG, EVONIK, EWE AG, FOND OF, Haniel, Hettich, Knauf, Körber, LANXESS, media + more venture Beteiligungs GmbH & Co. KG, PHOENIX CONTACT, QIAGEN, RWE Generation SE, SAP, Schufa, Schwarz Gruppe, STIHL, Thüga, Vector Informatik, WACKER and Wilh. Werhahn KG.
Media Contact
High-Tech Gründerfonds Management GmbH
Stefanie Grüter, Head of Marketing & Communications
T.: +49 228 – 82300 – 188
s.grueter@htgf.de
Investor Contact
High-Tech Gründerfonds Management GmbH
Daniela Bach, Senior Investment Manager
T.: +49 175 2525531
d.bach@htgf.de
Stay up to date
Subscribe now and receive the latest press releases on investments and other news from High-Tech Gründerfonds. We inform you about important developments at HTGF and provide you with interesting news from our portfolio. Whether it’s a successful exit, a new exciting investment or HR news – you’ll be the first to know!
Cultimate Foods raises 2.3 million EUR seed funding from leading Biotech and Foodtech investors to revolutionize the alternative meat industry
Successful Exit for HTGF: DocuWare Announces Acquisition of natif.ai
